1-201075508-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The ENST00000362061.4(CACNA1S):​c.1935C>A​(p.Phe645Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. F645F) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

CACNA1S
ENST00000362061.4 missense

Scores

9
5
4

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.45

Publications

0 publications found
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]
CACNA1S Gene-Disease associations (from GenCC):
  • congenital myopathy 18
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hypokalemic periodic paralysis, type 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • malignant hyperthermia, susceptibility to, 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: SD, AR, AD Classification: STRONG Submitted by: Illumina, Genomics England PanelApp
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.797

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000362061.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
NM_000069.3
MANE Select
c.1935C>Ap.Phe645Leu
missense
Exon 13 of 44NP_000060.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1S
ENST00000362061.4
TSL:1 MANE Select
c.1935C>Ap.Phe645Leu
missense
Exon 13 of 44ENSP00000355192.3
CACNA1S
ENST00000367338.7
TSL:5
c.1935C>Ap.Phe645Leu
missense
Exon 13 of 43ENSP00000356307.3
CACNA1S
ENST00000681874.1
c.1935C>Ap.Phe645Leu
missense
Exon 13 of 43ENSP00000505162.1

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460906
Hom.:
0
Cov.:
41
AF XY:
0.00
AC XY:
0
AN XY:
726760
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33450
American (AMR)
AF:
0.00
AC:
0
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53266
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111416
Other (OTH)
AF:
0.00
AC:
0
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.67
D
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.21
N
LIST_S2
Uncertain
0.93
D
M_CAP
Pathogenic
0.48
D
MetaRNN
Pathogenic
0.80
D
MetaSVM
Pathogenic
0.91
D
MutationAssessor
Benign
1.9
L
PhyloP100
-1.5
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.68
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.034
D
Polyphen
1.0
D
Vest4
0.79
MutPred
0.56
Gain of catalytic residue at F645 (P = 0.1797)
MVP
0.83
MPC
0.53
ClinPred
1.0
D
GERP RS
-3.9
Varity_R
0.73
gMVP
0.78
Mutation Taster
=37/63
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.42
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.42
Position offset: -13

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs550584336; hg19: chr1-201044636; API